Addressing Residual Risk in Ischaemic Heart Disease with Anti-Inflammatory Drugs: Between Scylla and Charybdis
Articolo
Data di Pubblicazione:
2021
Citazione:
Crea, F., Addressing Residual Risk in Ischaemic Heart Disease with Anti-Inflammatory Drugs: Between Scylla and Charybdis, <>, 2021; 42 (28): 2715-2719. [doi:10.1093/eurheartj/ehab450] [http://hdl.handle.net/10807/204005]
Abstract:
N/A
Tipologia CRIS:
Articolo in rivista, Nota a sentenza
Keywords:
Anti-Inflammatory Agents; Humans; Coronary Artery Disease; Myocardial Ischemia; Pharmaceutical Preparations
Elenco autori:
Crea, Filippo
Link alla scheda completa:
Pubblicato in: